Skip to main content
Log in

Cutaneous Metabolism of Nitroglycerin in Vitro. I. Homogenized Versus Intact Skin

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The metabolism of nitroglycerin (GTN) to 1,2- and 1,3-glyceryl dinitrate (GDN) by hairless mouse skin in vitro has been measured. In the first set of experiments, GTN was incubated with the 9000g supernatant of fresh, homogenized tissue in the presence and absence of glutathione (GSH), a cofactor for glutathione-S-transferase. After 2 hr of incubation with GSH, 30% of the initially present GTN had been converted to 1,2- and 1,3-GDN; without GSH, less than 5% of the GTN was metabolized. The ratio of 1,2-GDN to 1,3-GDN produced by the homogenate was 1.8– 2.1. In the second series of studies, GTN was administered topically to freshly excised, intact hairless mouse skin in conventional in vitro diffusion cells. The concurrent transport and metabolism of GTN was then monitored by sequential analysis of the receptor phase perfusing the dermal side of the tissue. Three topical formulations were used: a low concentration (1 mg/ml) aqueous solution, a 2% ointment, and a transder-mal delivery system. Delivery of total nitrates (GTN + 1,2-GDN + 1,3-GDN) into the receptor phase was similar for ointment and patch formulations and much greater than that from the solution. The percentage metabolites formed, however, was greatest for the solution (61% and 2 hr, compared to 49% for the patch and 35% for the ointment). As has been noted before, therefore, the relative level of skin metabolism is likely to be greatest when the transepidermal flux is small. Distinct from the homogenate experiments, the 1,2/1,3-GDN ratios in the penetration studies were in the range 0.7– 0.9. It would appear that homogenization of the skin permits GTN to be exposed to a different distribution of enzymes than that encountered during passive skin permeation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. P. K. Noonan and R. C. Wester. Cutaneous metabolism of xenobiotics. In R. L. Bronaugh and H. I. Maibach (eds.), Percutaneous Absorption, Dekker, New York, 1985, pp. 65–85.

    Google Scholar 

  2. D. A. W. Bucks. Skin structure and metabolism: Relevance to the design of cutaneous therapeutics. Pharm. Res. 1:148–153 (1984).

    Google Scholar 

  3. R. H. Guy, J. Hadgraft, and D. A. W. Bucks. Transdermal drug delivery and cutaneous metabolism. Xenobiotica 17:323–343 (1987).

    Google Scholar 

  4. R. J. Martin, S. P. Denyer, and J. Hadgraft. Skin metabolism of topically applied compounds. Int. J. Pharm. 39:23–32 (1987).

    Google Scholar 

  5. D. R. Bickers. The skin as a site of drug and chemical metabolism. In V. A. Drill and P. Lazar (eds.), Current Concepts in Cutaneous Toxicity, Academic Press, New York, 1980, pp. 95–125.

    Google Scholar 

  6. N. Higo, R. S. Hinz, D. T. W. Lau, L. Z. Benet, and R. H. Guy. Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement (accepted for publication) (1992).

  7. R. C. Wester, P. K. Noonan, S. Smeach, and L. Kosobud. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey. J. Pharm. Sci. 72:745–748 (1983).

    Google Scholar 

  8. G. C. Santus, N. Watari, R. S. Hinz, L. Z. Benet, and R. H. Guy. Cutaneous metabolism of transdermally delivered nitroglycerin in vitro. In B. Shroot and H. Schaefer (eds.), Skin Pharmacokinetics, Karger, Basel, 1987, pp. 240–244.

    Google Scholar 

  9. S. P. Denyer, W. B. Hugo, and M. O'Brien. Metabolism of glyceryl trinitrate by skin staphylococci. J. Pharm. Pharmacol. 36:61P (1984).

    Google Scholar 

  10. S. P. Denyer and C. McNabb. Microbial metabolism of topically applied drugs. In J. Hadgraft and R. H. Guy (eds.), Transdermal Drug Delivery, Dekker, New York, 1989, pp. 113–134.

    Google Scholar 

  11. E. Nakashima, P. K. Noonan, and L. Z. Benet. Transdermal bioavailability and first-pass skin metabolism: A preliminary evaluation with nitroglycerin. J. Pharmacokin. Biopharm. 15: 423–437 (1987).

    Google Scholar 

  12. F. W. Lee, N. Watari, J. Rigod, and L. Z. Benet. Simultaneous determination of nitroglycerin and its metabolites by capillary gas chromatography with electron-capture detection. J. Chromatogr. 426:259–266 (1981).

    Google Scholar 

  13. C. L. Gummer, R. S. Hinz, and H. I. Maibach. The skin cell: A design update. Int. J. Pharm. 40:101–104 (1987).

    Google Scholar 

  14. N. Bodor, J. Zupan, and S. Selk. Improved delivery through biological membranes VII: Dermal delivery of cromoglycic acid (cromolyn) via its prodrug. Int. J. Pharm. 7:63–75 (1982).

    Google Scholar 

  15. E. Boyland. The biological significance of metabolism of polycyclic compounds. Biochem. Soc. Symp. 5:40–54 (1960).

    Google Scholar 

  16. H. Marquardt, T. Kuroki, E. Humberman, J. K. Selkirk, C. Heidelberger, P. L. Grover, and P. Slims. Malignant transformation of cells derived from mouse prostate by epoxides and other derivatives of polycyclic hydrocarbons. Cancer Res. 32:716–720 (1972).

    Google Scholar 

  17. F. J. Di Carlo. Nitroglycerin revisited: chemistry, biochemistry, interactions. Drug Metab. Rev. 4:1–38 (1975).

    Google Scholar 

  18. S. H. Curry and S. M. Aburawi. Analysis, disposition and pharmacokinetics of nitroglycerin. Biopharm. Drug Dispos. 6:235–280 (1985).

    Google Scholar 

  19. P. Needleman and F. E. Hunter, Jr. The transformation of glyceryl trinitrite and other nitrites by glutathione-organic nitrate reductase. Mol. Pharmacol. 1:77–86 (1965).

    Google Scholar 

  20. P. A. Cossum and M. S. Roberts. Metabolite inhibition of nitroglycerin metabolism in sheep tissue homogenates. J. Pharm. Pharmacol. 37:807–809 (1985).

    Google Scholar 

  21. H. L. Fung, S. C. Sutton, and A. Kamiya. Blood vessel uptake and metabolism of organic nitrates in the rat. J. Pharmacol. Exp. Ther. 233:334–341 (1984).

    Google Scholar 

  22. P. K. Noonan and L. Z. Benet. Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration. Clin. Pharmacol. Ther. 237:629–635 (1986).

    Google Scholar 

  23. M. Katz and B. J. Poulsen. Absorption of drugs through the skin. In B. B. Brodie and J. R. Gillette (eds.), Handbook of Experimental Pharmacology, Springer-Verlag, New York, 1971, pp. 103–173.

    Google Scholar 

  24. S. W. Collier, N. M. Sheikh, A. Sakr, J. L. Lichtin, R. F. Stewart, and R. L. Bronaugh. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies. Toxicol. Appl. Pharmacol. 99:522–533 (1989).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Higo, N., Hinz, R.S., Lau, D.T.W. et al. Cutaneous Metabolism of Nitroglycerin in Vitro. I. Homogenized Versus Intact Skin. Pharm Res 9, 187–190 (1992). https://doi.org/10.1023/A:1018925004345

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018925004345

Navigation